What should we tackle next in acute myeloid leukemia? Wilms tumor gene 1 vaccine therapy would be a promising and versatile strategy for acute myeloid leukemia.

Nakata, Jun; Oji, Yusuke; Oka, Yoshihiro; Sugiyama, Haruo

Nakata, Jun; Oji, Yusuke; Oka, Yoshihiro; Sugiyama, Haruo.

Afiliação

Nakata J; a Department of Biomedical Informatics , Osaka University Graduate School of Medicine , Suita City, Osaka , Japan.
Oji Y; b Department of Functional Diagnosis , Osaka University Graduate School of Medicine , Suita City, Osaka , Japan.
Oka Y; c Department of Cancer Stem Cell Biology , Osaka University Graduate School of Medicine , Suita City, Osaka , Japan.
Sugiyama H; d Department of Cancer Immunology , Osaka University Graduate School of Medicine , Suita City, Osaka , Japan.

Expert Rev Hematol ; 12(4): 211-213, 2019 04.

Article em En | MEDLINE | ID: mdl-30882253

Assuntos

Vacinas Anticâncer/uso terapêutico; Genes do Tumor de Wilms; Leucemia Mieloide Aguda/terapia; Vacinas Anticâncer/genética; Regulação Neoplásica da Expressão Gênica; Transplante de Células-Tronco Hematopoéticas; Humanos; Imunoterapia Ativa; Leucemia Mieloide Aguda/genética; Regulação para Cima; Proteínas WT1/genética

Palavras-chave

Acute myeloid leukemia (AML); WT1 vaccine therapy; Wilms tumor 1 (WT1); cancer immunotherapy; cancer vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Genes do Tumor de Wilms / Vacinas Anticâncer Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google